SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NexGen Energy Ltd. engages in the acquisition, exploration and development of uranium properties. Its uranium project portfolio includes Arrow, South Arrow, Harpoon, Bow, IsoEnergy, SW1, SW2, SW3, and IsoEnergy properties. The company was founded by Leigh B. Curyer on March 8, 2011 and is headquartered in Vancouver, Canada.

NexGen Energy Ltd

NexGen Energy is trending as institutional interest intensifies and investors track critical federal permitting milestones for its Rook I project. The community is actively discussing the stock's role in the global uranium supply deficit, particularly as a key pure-play developer positioned to fuel the escalating energy demands of AI data centers.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

Dash is trending as investors monitor its potential to mirror the recent price appreciation of other privacy-focused assets like Zcash, with community members actively discussing a technical breakout and the impact of broader market volatility on its recovery. The ongoing discourse highlights a mix of long-term optimism regarding its privacy utility and tactical debates about potential entry points during the current price consolidation.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche (AVAX) is experiencing significant downward price volatility alongside the broader cryptocurrency market, leading to intense community debate between those panic-selling at multi-year lows and those aggressively accumulating to lower their average costs. Investors are closely monitoring the token's ability to maintain support levels while balancing long-term thesis-based optimism regarding institutional RWA tokenization against mounting frustration over its persistent underperformance relative to Bitcoin and other major altcoins.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Cameco is trending as investors focus on uranium as the essential backbone for AI-driven energy demand, with ongoing community discussion centered on nuclear's role as a critical, long-term power source. Sentiment is further buoyed by major recent supply deals and consistent institutional rotation into the sector, with many traders looking for a breakout above key psychological resistance levels.

Domino's Pizza, Inc. engages in the management of a network of company-owned and franchise-owned pizza stores. It operates through the following segments: U.S. Stores, International Franchise, and Supply Chain. The U.S. Stores segment consists primarily of franchise operations. The International Franchise segment comprises a network of franchised stores. The Supply Chain segment manages regional dough manufacturing and food supply chain centers. The company was founded by James Monaghan and Thomas Stephen Monaghan in 1960 and is headquartered in Ann Arbor, MI.

Dominos Pizza Inc

Dominos Pizza is trending due to mixed earnings, where a revenue beat and strong U.S. same-store sales growth have fueled investor optimism despite a slight bottom-line miss. The community is actively debating the company's growth strategy against macro headwinds, with some traders eyeing the stock for potential volatility after the recent earnings report.

Viper Energy, Inc. engages in the acquisition of oil and natural gas properties. It owns, acquires, and exploits oil and natural gas properties in North America. The company was founded on September 18, 2013 and is headquartered in Midland, TX.

Viper Energy Inc - Ordinary Shares - Class A

Viper Energy Partners LP

Viper Energy Partners is trending as investors monitor its strategic Permian Basin position and recent merger activities against a backdrop of global energy supply concerns. The community is actively discussing the stock's dividend potential and the long-term impact of its expanded asset footprint within the energy sector.

Fox Corp. engages in providing television production and broadcasting services. It also provides news under the brands FOX News Media, FOX Sports, FOX Entertainment and FOX Television Stations, and Tubi Media Group. It operates through the following segments: Cable Network Programming, Television, and Other and Corporate. The Cable Network Programming segment refers to the production and licensing of news and sports content distributed primarily through traditional cable television systems, direct broadcast satellite operators, and telecommunication companies and online multi-channel video programming distributors. The Television segment focuses on the acquisition, marketing, and distribution of broadcast network programming. The Other and Corporate segment relates to the FOX Studio Lot, Credible Labs Inc, corporate overhead costs, and intracompany eliminations. The company was founded by Keith Rupert Murdoch on May 3, 2018, and is headquartered in New York, NY.

Fox Corporation - Ordinary Shares - Class B

Fox Corporation - Class B

Fox Corporation is currently drawing market attention as investors weigh the company's long-term advertising resilience against ongoing concerns regarding media sentiment and content monetization strategies. Community discussions are heavily focused on the stock's positioning within the broader media sector, with market participants closely monitoring volatility as the company navigates evolving content distribution models.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is currently trending as investors monitor ongoing institutional accumulation and high short interest, fueling significant community speculation regarding a potential buyout or short squeeze. The stock remains a focal point due to clinical excitement surrounding its dual BAFF/APRIL inhibitor, atacicept, as the company progresses toward upcoming regulatory milestones.

Vanguard Index Funds - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF is seeing increased attention as market participants navigate broader volatility, persistent inflation concerns, and shifting geopolitical tensions related to Middle East conflicts. The community remains focused on long-term dollar-cost averaging strategies and debates surrounding the sustainability of tech-driven index growth amidst cooling macroeconomic indicators.

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.

Elicio Therapeutics Inc.

Elicio Therapeutics Inc

Elicio Therapeutics is gaining attention as investors anticipate pivotal data from the AMPLIFY-7P trial, with community sentiment largely focused on whether the company can successfully navigate its capital requirements to reach a potential buyout or major partnership. While the stock has seen high volatility, enthusiasts remain fixated on the therapeutic potential of ELI-002 as a multi-valent approach to targeting mKRAS-driven cancers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Biology Came First.

MindWalk Holdings Corp. (NASDAQ: HYFT) today released a systematic report identifying over 20 discovery-originated drug candidates with documented origins in antibody discovery work performed at...

Xencor (XNCR) Reports Q1 Loss, Lags Revenue Estimates

Xencor (XNCR) delivered earnings and revenue surprises of -164.58% and -75.38%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Xencor Reports First Quarter 2026 Financial Results

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported financial results for the...

Xencor Highlights XmAb942 Phase 1 Data, Previews TL1A/IL-23 Bispecific XmAb412 at DDW 2026

Xencor (NASDAQ:XNCR) used a webcast during Digestive Disease Week 2026 to highlight Phase I results for its TL1A-targeting monoclonal antibody XmAb942 and to outline preclinical data supporting...

Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported final results from the...

Corcept Therapeutics (CORT) Reports Q1 Loss, Misses Revenue Estimates

Corcept (CORT) delivered earnings and revenue surprises of -1.11% and -4.37%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Xencor (XNCR) Projected to Post Earnings on Wednesday

Xencor (NASDAQ:XNCR) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-xencor-inc-stock...

Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Xencor, Inc. (NASDAQ:XNCR - Get Free Report) have received a consensus rating of "Moderate Buy" from the nine analysts that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assig...

Xencor (NASDAQ:XNCR) Stock Price Down 8% - Should You Sell?

Xencor (NASDAQ:XNCR) Shares Down 8% - Here's What Happened...

Xencor (NASDAQ:XNCR) Stock Passes Above 50 Day Moving Average - Time to Sell?

Xencor (NASDAQ:XNCR) Stock Price Passes Above 50-Day Moving Average - What's Next...

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

XNCRXencor Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest XNCR News